» Articles » PMID: 38258137

Correction: Yadav Et Al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression Via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. 2022, , 1326

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2024 Jan 23
PMID 38258137
Authors
Affiliations
Soon will be listed here.
Abstract

In the published publication [...].

References
1.
Yadav N, Tripathi A, Parveen A, Parveen S, Banerjee M . PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics. 2022; 14(7). PMC: 9323198. DOI: 10.3390/pharmaceutics14071326. View